---
title: DMCM2019 Draft
layout: default
permalink: /DMCM2019_draft
---

<img src="../images/places/Sevilla24.jpg" alt="Sevilla"/>

The 2019 community meeting is hosted by the <a href="http://www.clinbioinfosspa.es/">Clinical Bioinformatics Area, FPS, Hospital Virgen del Rocio</a>.

## Programme

### Wednesday 2nd October

<table>
<tr><td><strong>09:00 Disease Maps Members/Coordinators Meeting</strong></td></tr> 
</table>

<p><strong><i>10:30 Coffee Break</i></strong></p>

#### Session 1: Using existing data to create disease maps

<table>
<tr><td><strong>11:00 Welcome</strong><br>Joaquin Dopazo. Clinical Bioinformatics Area, FPS. Sevilla, Spain</td></tr> 
<tr><td><strong>11:10 Opening Key Lecture 1: <br />Analysis of multi-omics data to improve the understanding of Parkinson’s disease.
</strong><br />Inge Jonassen, University of Bergen, Norway</td></tr> 
<!-- <a href="#"><b><font color="Navy"><span style="text-decoration: underline;">Abstract</span></font></b></a> -->
<tr><td><strong>12:10 Short talks:<br /> Towards automatic assembly and management of evolving disease models: modularisation, merging, layout, comparison and versioning. </strong><br /><i>Alexander Mazein. University of Luxembourg. Luxembourg</i><br />
<br /><strong>Common disease mechanisms at play? A modelling challenge.</strong><br /><i>Rudi Balling. University of Luxembourg, LCSB. Luxembourg </i><br /><br /><strong>Disease map for aHUS – molecular mechanisms and hypotheses.</strong><br /><i>Tatiana Serebriyskaya. RacursBioMed Ltd. Russia</i><br /><br /><strong>A disease map and a database for cystic fibrosis.</strong><br /><i>Catarina Pereira. University of Lisboa Faculty of Sciences, BioISI – Biosystems and Integrative Science Institute, Lisboa, Portugal</i></td></tr> 
<tr><td><strong>14:00 Lunch and Poster viewing</strong><br /></td></tr> 
</table>

#### Session 2: Computational models

<table>
<tr><td><strong>15:30 Key Lecture 2: Toward whole-cell computational models for precision medicine</strong><br />
Jonathan Karr, Icahn School of Medicine at Mount Sinai, New York, USA<br /></td></tr> 
<tr><td><strong>16:30 Short talks:<br />A multiscale modelling platform to simulate drug synergies in different cell population architectures.</strong><br /><i>Miguel Ponce de Leon. Barcelona Supercomputing Center. Barcelona, Spain</i><br /><br /><strong>The metabolite abundances in coherence with the activities of signalling pathway circuits. </strong><br /><i>Cankut Cubuk. Clinical Bioinformatics Area, FPS. Sevilla, Spain</i><br /><br /><strong>Executable Disease Maps – Addressing the challenges of large scale dynamical modelling. </strong><br /><i>Anna Niarakis. GenHotel, University of Evry, Paris-Saclay</i></td></tr> 
</table>

### Thursday 3rd October

#### Session 3: Multi-view data integration

<table>
<tr><td><strong>9:00 Key Lecture: <br/>Logic modelling to integrate disease maps and various omics data</strong><br />
Julio Saez-Rodriguez,RWTH-Aachen University Hospital, Aachen, Germany<br /></td></tr> 
<tr><td><strong>10:00 Highlighted talk: <br/>Elixir</strong><br /></td></tr> 
</table>

<p><strong><i>10:30 Coffee break and poster viewing</i></strong></p>

<table>
<tr><td><strong>11:00 Selected short talks:</strong><br /><strong>Atlas of Cancer Signaling Network: a resource of multi-scale biological maps to study disease mechanisms.</strong><br /><i>Luis Cristobal Monraz Gomez. Institut Curie. France</i><br/><br /><strong>Collaborative construction and visual analysis of biological pathways with Newt 2.0. 
</strong><br /><i>Ugur Dogrusoz. Bilkent University. Turkey</i><br /><br /><strong>Reactome Pathway Analysis and Visualization.</strong><br /><i>Henning Hermjakob. EMBL-EBI. United Kingdom</i></td></tr>

<tr><td><strong>12:30 Poster session: <br/>Flash presentations</strong><br /></td></tr> 
</table>

<p><strong><i>13:30 Lunch and poster viewing</i></strong></p>

#### Session 4: Discussions

<table>
<tr><td><strong>15:00 Introduction</strong></td></tr> 
<tr><td><strong>15:30  Discussion topics: </strong><br/><i>Four discussion sessions (Topics to be determined)</i>
</td></tr> 
<tr><td><strong>17:30 Presentation preparation and final discussion
</strong></td></tr> 
<tr><td><strong>18:30 Results presentation
</strong></td></tr> 
<tr><td><strong><font color="Navy">20:30 Gala Dinner</font></strong></td></tr> 
</table>

<!-- Afternoon breakout discussion sessions are planned following the example of the [2nd Disease Maps Community Meeting](http://disease-maps.org/DMCM2017_2nd) in Luxembourg. We invite proposals: a title and a brief description of the topic (1 page maximum). 4-6 topics will be selected, introduced 2nd October and discussed 3rd and 4th October with summaries presented at the end to all the participants. The outcome of the Luxembourg meeting discussions was published receintly in _Briefings in Bioinformatics_: [doi: 10.1093/bib/bby024](https://doi.org/10.1093/bib/bby024). -->

<!-- <p><strong>17:00 - 18:00 Concluding remarks</strong></p> -->

### Friday 4th October

#### Session 5: Clinical application of disease maps

<table>
<tr><td><strong>09:00 Key Lecture 4:<br/>Computational approaches to tackle chemoresistance in high-grade serous ovarian cancer.</strong><br />
Sampsa Hautaniemi, Faculty of Medicine, University of Helsinki, Finland<br /></td></tr> 
<tr><td><strong>10:00 The DisGeNET platform’s 10 anniversary: <br/>Developing a knowledge base for disease genomics.</strong><br /><i>Janet Piñero. GRIB (IMIM-UPF). Spain</i></td></tr> 
</table>

<p><strong><i>10:30 Coffee break</i></strong></p>

<table>
<tr><td><strong>11:00 Short talks:<br/>The druggable landscape of Familial melanoma: Using machine learning and mechanistic models to screen for putative functional drug-targets.</strong><br /><i>Marina Esteban-Medina. Clinical Bioinformatics Area, FPS. Sevilla, Spain</i><br /><br /><strong>Connecting metabolic biomarkers with biological pathways and clinical data to enable omics data interpretation.</strong><br /><i>Denise N. Slenter. Maastricht University. Netherlands</i><br /><br /><strong>Interactive visualization of phenotypic and genotypic information in disease maps for identification of mechanistic biomarkers.</strong><br /><i>Sascha Herzinger. University of Luxembourg, Luxembourg Centre for Systems Biomedicine. Luxembourg</i></td></tr> 
</table>

<p><strong><i>12:30 Lunch</i></strong></p>

<!--### Afternoon discussion sessions
Afternoon breakout discussion sessions are planned following the example of the [2nd Disease Maps Community Meeting](http://disease-maps.org/DMCM2017_2nd) in Luxembourg. We invite proposals: a title and a brief description of the topic (1 page maximum). 4-6 topics will be selected, introduced 2nd October and discussed 3rd and 4th October with summaries presented at the end to all the participants. The outcome of the Luxembourg meeting discussions was published receintly in _Briefings in Bioinformatics_: [doi: 10.1093/bib/bby024](https://doi.org/10.1093/bib/bby024).-->

#### Hands-on session

<p>Tutorials of the following tools and resources:</p>

<table>
<tr><td><strong>14:30 Newt</strong></td></tr> 
<tr><td><strong>14:30 BiNoM, ACSN</strong></td></tr> 
<tr><td><strong>15:30 MINERVA</strong></td></tr> 
<tr><td><strong>15:30 Hipathia</strong></td></tr> 
</table>

<p>(Depending on computers and rooms available, will be distributed in one or two parallel hands-on sessions)</p>

<p><strong><i>17:00h Meeting closure </i></strong></p>
